"EU MDR" requires Device Makers to have proactive post-market surveillance (PMS) of their products in market in the EU. Talosix provides a risk-appropriate, holistic PMS solution for Device Makers to stay in market.Learn more
CMS is increasingly requiring real world evidence of patient outcomes to secure and maintain reimbursement coverage of procedures. Talosix delivers RWE of performance to make the case for coverage.Learn more
Talosix’s “Machine Learning Center of Excellence” partners with top tier academic hospitals to develop intelligent products powered by clinical data.
Talosix has in-house Clinical, Medical Device, Health Economics, and Biostatistics expertise for developing strategies and solutions to meet client objectives.
Talosix leverages proprietary technology for collecting and storing sensitive Protected Health Information in a highly secure manner.
Talosix’s RWE Platform collects, stores, analyzes, and reports out clinical and non-clinical data from real world settings. Our artificial intelligence adds automation and prediction capabilities to increase the return on client’s investment in data.
Proprietary technology for collecting and analyzing real world data from patients and the point of care.
In-house Clinical, Device Maker, and Biostatistics expertise for delivering personalized client solutions.
Proprietary technology for securely collecting and storing sensitive Protected Health Information.
Pre-built AI models and infrastructure for configuration to client's personalized requirements.
To learn more about how Talosix can help you unlock the power of technology and artificial intelligence for your patients, please contact us.Contact Sales